Y Intercept Hong Kong Ltd Buys 27,984 Shares of Cardinal Health, Inc. (NYSE:CAH)

Y Intercept Hong Kong Ltd increased its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 258.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,816 shares of the company's stock after buying an additional 27,984 shares during the period. Y Intercept Hong Kong Ltd's holdings in Cardinal Health were worth $5,348,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the company. Pinnacle Bancorp Inc. raised its position in Cardinal Health by 11.2% during the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock valued at $106,000 after purchasing an additional 77 shares during the period. CSS LLC IL raised its position in Cardinal Health by 0.8% during the fourth quarter. CSS LLC IL now owns 11,190 shares of the company's stock valued at $1,323,000 after purchasing an additional 90 shares during the period. Perigon Wealth Management LLC raised its position in Cardinal Health by 4.2% during the first quarter. Perigon Wealth Management LLC now owns 2,242 shares of the company's stock valued at $309,000 after purchasing an additional 90 shares during the period. Smith Shellnut Wilson LLC ADV raised its position in Cardinal Health by 2.1% during the first quarter. Smith Shellnut Wilson LLC ADV now owns 4,399 shares of the company's stock valued at $606,000 after purchasing an additional 91 shares during the period. Finally, TIAA Trust National Association raised its position in Cardinal Health by 4.5% during the fourth quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock valued at $258,000 after purchasing an additional 94 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.3%

NYSE:CAH traded up $0.41 during midday trading on Thursday, hitting $158.17. The stock had a trading volume of 1,405,858 shares, compared to its average volume of 2,403,561. Cardinal Health, Inc. has a one year low of $96.05 and a one year high of $168.44. The company has a market capitalization of $37.75 billion, a price-to-earnings ratio of 24.67, a PEG ratio of 1.56 and a beta of 0.68. The stock has a 50-day moving average of $159.06 and a 200 day moving average of $140.89.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.20. The company had revenue of $54.88 billion for the quarter, compared to analysts' expectations of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. Cardinal Health's revenue was up .0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.08 earnings per share. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st were given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.29%. The ex-dividend date of this dividend was Tuesday, July 1st. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio (DPR) is 31.83%.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of recent research reports. Wells Fargo & Company upgraded Cardinal Health from an "equal weight" rating to an "overweight" rating and upped their price objective for the company from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Morgan Stanley increased their price target on Cardinal Health from $181.00 to $190.00 and gave the stock an "overweight" rating in a report on Wednesday, July 16th. Mizuho increased their price target on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a report on Monday, March 31st. Bank of America increased their price target on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a report on Tuesday, June 10th. Finally, Citigroup reiterated a "neutral" rating and issued a $170.00 price target (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Cardinal Health currently has an average rating of "Moderate Buy" and an average target price of $158.07.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.